Recurrent Prostate Cancer
Recurrent Prostate Cancer is when prostate cancer returns after treatment, which can happen months or years later. It may require further treatment and monitoring.
Prostate Cancer: CC 1 Antibody Study
We are evaluating a new antibody treatment for men whose prostate cancer has returned. The study aims to assess its safety and early signs of effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Tuebingen AöR
KKE Translationale Immunologie
Tübingen, Germany
Sponsor: Universitaetsklinikum Tuebingen AöR
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.